Authorized Representative
๐ฉ๐ฐ Denmark
Active
Agilent Technologies Denmark ApS
SRN: DK-AR-000001443
ยท
Produktionsvej 42, 2600 Glostrup, Denmark
Manufacturers
3
Devices
176
Certificates
0
PRRCs
1
Basic Information
- Address
- Produktionsvej 42, 2600 Glostrup, Denmark
- [email protected]
- Phone
- +45 44 85 95 00
- Website
- https://www.agilent.com/
- VAT Number
- 1005253004
Non-EU Manufacturers
| Name | Country | SRN |
|---|---|---|
| Agilent Technologies Singapore (International) Pte Ltd | ๐ธ๐ฌ Singapore | SG-MF-000014448 |
| Agilent Biosciences (Hangzhou) Co., Ltd. | ๐จ๐ณ China | CN-MF-000013066 |
| Agilent Technologies, Inc. | ๐บ๐ธ United States | US-MF-000009385 |
Manufacturers
Agilent Biosciences (Hangzhou) Co., Ltd.
Manufacturer
๐จ๐ณ China·115 Basic UDI-DIs·123 Devices
Agilent Technologies, Inc.
Manufacturer
๐บ๐ธ United States·8 Basic UDI-DIs·48 Devices
Agilent Technologies Singapore (International) Pte Ltd
Manufacturer
๐ธ๐ฌ Singapore·5 Basic UDI-DIs·5 Devices
Devices
NovoCyte Quanteon Dx Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Advanteon Dx Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
NovoCyte Flow Cytometer
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR HLA CLASS II DETERMINANTS
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
MONOCLONAL ANTIBODIES FOR CYTOPLASMATIC ANTIGENS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
MONOCLONAL ANTIBODIES FOR CYTOPLASMATIC ANTIGENS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
MONOCLONAL ANTIBODIES FOR CYTOPLASMATIC ANTIGENS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
MONOCLONAL ANTIBODIES FOR CYTOPLASMATIC ANTIGENS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR B AND T-CELL SUBTYPING
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
LYMPHOKINES /IMMUNMODULATORS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
LYMPHOKINES /IMMUNMODULATORS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
GenetiSure Dx Cot-1 Human DNA
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Wash Buffer 1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Wash Buffer 2
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Hybridization Kit
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Labeling Kit
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Labeling Kit Purification Columns
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
GenetiSure Dx Postnatal Assay
Device
EU IVDR
·
Eu Ivd Class C
·Agilent Technologies, Inc.·On the market·1 country
Agilent CytoDx Software
Device
EU IVDR
·
Eu Ivd Class C
·Agilent Technologies, Inc.·On the market·1 country
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy H1
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch 2
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch 2
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch 2
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch 2
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Epoch
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
Synergy HTX
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
800TS
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies, Inc.·On the market
BenchLab CNV Software
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies Singapore (International) Pte Ltd·On the market
Alissa Interpret
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies Singapore (International) Pte Ltd·On the market
AriaDx Real-Time PCR Instrument
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies Singapore (International) Pte Ltd·On the market·1 country
SureScan Dx Microarray Scanner
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies Singapore (International) Pte Ltd·On the market·1 country
MagnisDx NGS Prep System
Device
EU IVDR
·
Eu Ivd Class A
·Agilent Technologies Singapore (International) Pte Ltd·On the market·1 country